Related Experiment Videos
Aggregation between teratocarcinoma cells and preimplantation mouse embryos
Journal of Embryology and Experimental Morphology
|August 1, 1980
Summary
Two embryonal carcinoma cell lines, F9 and PC13, can aggregate with early mouse embryos. These aggregates develop into blastocysts, with EC cells often integrating into the inner cell mass.
Area of Science:
- Developmental biology
- Stem cell research
- Mammalian embryogenesis
Background:
- Embryonal carcinoma (EC) cells are pluripotent stem cells derived from teratocarcinomas.
- Understanding stem cell-embryo interactions is crucial for developmental biology and regenerative medicine.
Purpose of the Study:
- To investigate the aggregation potential of F9 and PC13 embryonal carcinoma cell lines with preimplantation mouse embryos.
- To determine if EC cells can integrate into early embryonic structures.
Main Methods:
- Co-culture of F9 and PC13 EC cell lines with 8-cell stage mouse embryos.
- Observation of cell adhesion, compaction, and subsequent development in vitro.
- Analysis of aggregate morphology and cell localization within resulting blastocysts.
Main Results:
- Both F9 and PC13 EC cell lines adhered to and compacted with 8-cell mouse embryos.
- Aggregates successfully developed into blastocysts in culture.
- EC cells were frequently found within the inner cell mass of the resultant blastocysts.
- Differentiated EC cell derivatives (PYS-1, PYS-2) and STO fibroblasts did not aggregate with embryos.
Conclusions:
- F9 and PC13 EC cells possess the ability to interact with and integrate into early mouse embryos.
- This suggests a potential for EC cells to contribute to embryonic lineages, specifically the inner cell mass.
- Differentiated cell types lack the capacity for such early embryonic aggregation.